Skip to main content

Ocugen, Inc.

OCGN
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
SEC CIK
0001372299

In the last 90 days, Ocugen, Inc. insiders filed 0 open-market purchases and 1 sale; 147 institutions reported holding it in 13F filings for Q2 2026, worth $222.1M in total; no superinvestor holds it.

Q1 2024 vs. Q4 2023

How the institutions holding Ocugen, Inc. changed between Q4 2023 and Q1 2024.

All holders in Q1 2024All holders in Q4 2023

13F holders of OCGN: Q4 2023 compared with Q1 2024
MeasureQ4 2023Q1 2024Change
Holders6881+13
Shares26.3M33.0M+6.71M (+25.6%)
Value$15.1M$54.0M+$38.9M (+257.6%)

New holders (27)

Institutions that held Ocugen, Inc. at the end of Q1 2024 but not at the end of Q4 2023.

Institutions new to OCGN in Q1 2024
InstitutionSharesValue% of portfolio
Goldman Sachs Group Inc2,607,625$4.28M0.00%
HRT Financial LP806,500$1.32M0.01%
Squarepoint Ops LLC143,393$235.2K0.00%
Y-Intercept (Hong Kong) Ltd128,825$211.3K0.02%
Balyasny Asset Management LLC110,836$181.8K0.00%
Brevan Howard Capital Management LP69,268$113.6K0.01%
Omers Administration Corp67,400$110.5K0.00%
Toroso Investments, LLC66,009$108.3K0.00%
CTC Alternative Strategies, Ltd.62,800$103.0K0.06%
State Board of Administration of Florida Retirement System80,676$68.8K0.00%
Headlands Technologies LLC40,198$65.9K0.02%
Catalyst Funds Management Pty Ltd33,960$55.7K0.02%
DRW Securities, LLC24,200$39.7K0.00%
Wolverine Trading, LLC23,528$38.6K0.00%
David J Yvars Group21,170$34.7K0.02%
Truefg, LLC21,000$34.4K0.01%
Raleigh Capital Management Inc.20,000$32.8K0.01%
Raymond James & Associates18,100$29.7K0.00%
Symmetry Investments LP15,000$24.6K0.00%
Gainplan LLC13,960$22.9K0.01%
Blair William & Co12,954$21.2K0.00%
TCG Advisory Services, LLC10,964$18.0K0.00%
South State Corp.7,000$11.5K0.00%
Ronald Blue Trust, Inc.500$8200.00%
Citadel Advisors LLC336$5510.00%
Huntington National Bank124$2030.00%
Macquarie Group Ltd5,883$100.00%

Sold out (14)

Institutions that held Ocugen, Inc. at the end of Q4 2023 and filed for Q1 2024 without it.